Does a female patient with short stature, delayed puberty, primary amenorrhea, streak gonads, webbed neck, and low hairline have Turner syndrome?

Turner Syndrome Diagnosis

Yes, this clinical presentation is highly consistent with Turner syndrome and warrants immediate karyotype analysis to confirm the diagnosis. The constellation of short stature, delayed puberty, primary amenorrhea, streak gonads, webbed neck, and low hairline represents the classic phenotype of Turner syndrome 1, 2.

Diagnostic Confirmation

• Karyotype analysis on peripheral blood lymphocytes is the definitive diagnostic test and should be performed immediately in any female presenting with this combination of features 1, 3.
• The karyotype will typically reveal complete or partial loss of one X chromosome, most commonly 45,X (monosomy X), though mosaic patterns (e.g., 45,X/46,XX) occur in approximately 50% of cases 3, 2.
• Even mosaic karyotypes with a minority of 45,X cells (as low as 10-21%) can produce the full Turner syndrome phenotype and associated cardiovascular risks 4, 5.

Key Clinical Features Supporting the Diagnosis

Physical manifestations:

• Short stature is present in nearly all cases and is often the presenting feature in childhood 1, 2.
• Webbed neck (pterygium colli) and low posterior hairline are classic stigmata present in a significant proportion of patients 2, 5.
• Streak gonads (ovarian dysgenesis) with hypergonadotropic hypogonadism lead to primary amenorrhea and absent pubertal development in untreated patients 1, 3.

Endocrine findings:

• Primary amenorrhea with elevated FSH and LH levels (hypergonadotropic hypogonadism) confirms ovarian failure 3, 2.
• Delayed or absent spontaneous puberty occurs due to streak gonads that lack functional ovarian tissue 1, 6.

Critical Immediate Evaluations Required

Once karyotype confirms Turner syndrome, comprehensive cardiovascular assessment is mandatory:

• Cardiac MRI and transthoracic echocardiography must be performed at diagnosis to screen for bicuspid aortic valve (present in 15-30% of cases), aortic coarctation (7-18%), and ascending aortic dilation (33%) 7, 8.
• Cardiovascular disease, particularly aortic dissection, is the leading cause of death in Turner syndrome, with a six-fold increased risk compared to the general population 7.
• For patients ≥15 years old, calculate the aortic size index (ASI = maximal aortic diameter in cm ÷ body surface area in m²) to assess dissection risk; ASI >2.0 cm/m² is abnormal and ASI ≥2.5 cm/m² warrants consideration of prophylactic surgical intervention 7, 8.

Additional baseline assessments:

• Renal ultrasound to evaluate for congenital malformations (horseshoe kidney, duplicated collecting system) 6, 2.
• Thyroid function tests and thyroid antibodies, as autoimmune thyroiditis is common 3, 6.
• Fasting glucose and lipid profile to screen for metabolic abnormalities 3, 2.
• Audiometry to detect sensorineural hearing loss 6, 2.

Management Priorities

Estrogen replacement therapy:

• Begin low-dose transdermal estrogen (6.25 mcg/day via patch) or oral micronized estradiol (5 mcg/kg/day or 0.25 mg/day) to initiate pubertal development 1.
• Gradually increase estrogen dose over 2-3 years to adult replacement levels (transdermal 100-200 mcg/day or oral 2-4 mg/day) 1.
• Add cyclic progestogen (micronized progesterone 100-200 mg/day or dydrogesterone 5-10 mg/day for 12-14 days monthly) after 2 years of estrogen or when breakthrough bleeding occurs 1.

Cardiovascular surveillance:

• Patients without cardiovascular abnormalities require imaging every 10 years in adulthood 7, 8.
• Patients with ASI >2.3 cm/m² require at least annual surveillance imaging 7, 8.
• Aggressive blood pressure control is critical, as hypertension is a major modifiable risk factor for aortic dissection 7, 9.

Common Pitfalls to Avoid

• Do not delay karyotype testing in females with unexplained short stature or primary amenorrhea, as the average age at diagnosis is 15 years despite often conspicuous features 3.
• Do not use general population z-scores for aortic measurements in children <15 years, as this overestimates risk; use Turner-specific z-scores instead 7.
• Do not initiate estrogen therapy before comprehensive cardiovascular evaluation, as undiagnosed aortic pathology increases dissection risk 7, 4.
• Do not assume mosaic karyotypes confer lower risk; even small percentages of 45,X cells mandate full Turner syndrome cardiovascular protocols 4, 5.